Lower profit due to strategic pricing and quality-control costs associated with expanding overseas medical-equipment sales

「In medical equipment, additional costs were incurred to replace parts in connection with durability issues that arose in the previous consolidated fiscal year, resulting in operating income of ¥1.781 billion, down 23.9% year on year.」

「Medical equipment costs increased because some newly adopted components had durability problems and had to be replaced」

「Sales in the Mechatronics Systems Business increased from the same period of the previous year, as semiconductor manufacturing systems saw higher sales of LED bonders and inspection equipment to Thailand, while medical equipment sales to overseas markets including North America and Southeast Asia were strong and increased substantially.」

「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales declined slightly because the Chinese economy remained stagnant and demand had not yet reached a full-scale recovery. Cutting machine sales also declined due to weak domestic demand in the metalworking industry, but medical equipment sales to overseas markets, including Europe, North America and India, increased significantly.」

「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales were flat and cutting machine sales declined, but medical equipment sales to overseas markets, including Europe, North America and India, increased.」

「Sales in the Mechatronics Systems Business increased from the same period of the previous year, as semiconductor manufacturing equipment sales rose on higher sales of wire bonders for LEDs to China and medical equipment sales increased on strong sales to Europe.」

「Medical equipment sales increased as overseas markets including India, Europe and South Korea recovered from the substantial decline caused by the impact of COVID-19, although」

「Medical equipment sales increased from the same period of the previous year as overseas markets including India, Europe and South Korea recovered from the substantial decline caused by the impact of COVID-19.」

「Medical equipment sales increased from the same period of the previous year as overseas markets including India, Europe, South Korea and Taiwan recovered from the substantial decline caused by the impact of COVID-19.」

「Revenue from the Mechatronics Systems business increased year on year. Sales of semiconductor manufacturing equipment to China declined significantly due to the economic slowdown caused by the country’s zero-COVID policy, but overseas medical equipment sales, including to India, Southeast Asia and Europe, recovered rapidly from the sharp decline caused by COVID-19 and increased significantly.」

「Medical equipment sales increased as overseas markets, including India and Europe, which had suffered a substantial decline due to the impact of COVID-19, began to recover」

「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales increased against the backdrop of expanding capital investment demand in China aimed at improving semiconductor self-sufficiency, as in the previous fiscal year. Medical equipment sales also recovered slightly from the sharp decline in the previous fiscal year, despite continued weakness in demand for dialysis equipment due to the impact of COVID-19.」

「Operating profit was ¥1.070 billion, up 86.2% year on year, mainly because the sales mix of highly profitable semiconductor manufacturing equipment increased and medical equipment production remained at a high level, reducing the fixed-cost burden.」

「Revenue from the Mechatronics Systems business increased year on year. Sales of semiconductor manufacturing equipment to China declined due to the impact of US-China trade friction, but medical equipment sales increased on strong sales in Japan, China and Europe. As a result, consolidated revenue was ¥14,076 million, up 8.0% year on year. In terms of earnings, operating profit was ¥729 million, up 203.5% year on year, mainly because the sales mix shifted toward more profitable semiconductor manufacturing equipment models.」

「Sales in the Mechatronics Systems Business increased from the previous consolidated fiscal year. Although sales of cutting and processing machines declined, medical equipment sales increased on strong sales to India, China and Europe, while semiconductor manufacturing equipment sales increased on strong sales to China. As a result, consolidated net sales rose 14.6% year on year to ¥30.192 billion, and operating profit rose 18.8% to ¥1.664 billion.」

「As a result, consolidated net sales increased to ¥19.573 billion, up 3.8% year on year. In terms of earnings, however, operating profit declined 43.5% year on year to ¥574 million, particularly because the company adopted strategic pricing to expand medical equipment sales in overseas markets and incurred higher costs to improve quality control.」

「Sales in the Mechatronics Systems business increased year on year. Although medical equipment sales declined slightly, cutting machine sales rose modestly and semiconductor manufacturing equipment sales increased substantially on strong sales to China and South Korea. As a result, consolidated net sales increased 12.7% to ¥13,029 million. On the earnings front, however, operating income declined 47.5% to ¥240 million because the company adopted strategic pricing, particularly for medical equipment, to expand sales in overseas markets, while costs rose to improve quality control.」